Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118376642 | 11837664 | 2 | F | 20150109 | 20160729 | 20151215 | 20160804 | EXP | FR-ABBVIE-15P-056-1520265-00 | ABBVIE | 55.00 | YR | F | Y | 0.00000 | 20160804 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118376642 | 11837664 | 1 | PS | DEPAKOTE | DIVALPROEX SODIUM | 1 | Oral | U | UNKNOWN | 18723 | 500 | MG | GASTRO-RESISTANT COATED TABLET | TID | |||||
| 118376642 | 11837664 | 2 | SS | DEPAKOTE | DIVALPROEX SODIUM | 1 | Oral | U | UNKNOWN | 18723 | 1.5 | G | GASTRO-RESISTANT COATED TABLET | QD | |||||
| 118376642 | 11837664 | 3 | SS | DEPAKOTE | DIVALPROEX SODIUM | 1 | Oral | U | UNKNOWN | 18723 | 1.25 | G | GASTRO-RESISTANT COATED TABLET | QD | |||||
| 118376642 | 11837664 | 4 | SS | EPIRUBICINE | EPIRUBICIN | 1 | Intravenous (not otherwise specified) | N | UNKNOWN | 0 | 100 | MG | Q3W | ||||||
| 118376642 | 11837664 | 5 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | N | UNKNOWN | 0 | 500 | MG | Q3W | ||||||
| 118376642 | 11837664 | 6 | SS | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | N | UNKNOWN | 0 | 500 | MG | Q3W | ||||||
| 118376642 | 11837664 | 7 | SS | CLOPIXOL | ZUCLOPENTHIXOL ACETATE | 1 | Oral | U | UNKNOWN | 0 | 20 | GTT | ORAL DROPS, SOLUTION | QD | |||||
| 118376642 | 11837664 | 8 | SS | CLOPIXOL | ZUCLOPENTHIXOL ACETATE | 1 | Oral | U | UNKNOWN | 0 | 15 | GTT | ORAL DROPS, SOLUTION | QD | |||||
| 118376642 | 11837664 | 9 | C | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118376642 | 11837664 | 1 | Product used for unknown indication |
| 118376642 | 11837664 | 4 | Product used for unknown indication |
| 118376642 | 11837664 | 5 | Product used for unknown indication |
| 118376642 | 11837664 | 6 | Product used for unknown indication |
| 118376642 | 11837664 | 7 | Product used for unknown indication |
| 118376642 | 11837664 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118376642 | 11837664 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118376642 | 11837664 | Febrile neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118376642 | 11837664 | 4 | 20141126 | 20150109 | 0 | |
| 118376642 | 11837664 | 5 | 20141126 | 20150109 | 0 | |
| 118376642 | 11837664 | 6 | 20141126 | 20150109 | 0 |